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Abstract. 
 
Among the members of the prohormone 
convertase (PC) family, PC2 has a unique maturation 
pattern: it is retained in the ER for a comparatively 
long time and its propeptide is cleaved in the TGN/
secretory granules rather than in the ER. It is also 
unique by its association with the neuroendocrine pro-
tein 7B2. This interaction results in the facilitation of 
proPC2 maturation and in the production of activatable 
proPC2 from CHO cells. In the present study, we have 
investigated the mechanism of this interaction.
ProPC2 binds 7B2 in the ER, but exits this compart-
ment much more slowly than 7B2. We found that 
proPC2 was also slow to acquire the capacity to bind 
7B2, whereas 7B2 could bind proPC2 rapidly after syn-
thesis. This indicated that proPC2 folding was the limit-
ing step in the formation of the complex. Indeed, sensi-
tivity of native proPC2 to 
 
N
 
-glycanase F digestion and 
inhibition of proPC2 folding supported the notion that 
7B2 is not involved in the early steps of proPC2 folding, 
and that proPC2 must fold before binding 7B2. Under 
experimental conditions that prevent propeptide cleav-
age, 7B2 expression increased proPC2 transport to the 
Golgi. This increase exhibited the same kinetics as the 
facilitation of the removal of the propeptide. Finally, 
proPC2 activation could be reconstituted in Golgi-
enriched subcellular fractions. In vitro, 7B2 was re-
quired for proPC2 activation at an acidic pH.
Taken together, our results demonstrate that rather 
than promoting proPC2 folding, 7B2 acts as a helper 
protein involved in proPC2 transport and is required in 
the proPC2 activation process. We propose, therefore, 
that 7B2 stabilizes proPC2 in a conformation already 
competent for these two events.
 
T
 
he 
 
major posttranslational modifications that result
in the production of active peptides are endopro-
teolytic cleavage of the precursor, followed by exo-
proteolytic cleavage, and NH
 
2
 
-terminal acetylation and/or
COOH-terminal amidation. The enzymes responsible for
endoproteolytic cleavage events have recently been cloned
(for review see Seidah and Chretien, 1994; Rouille et al.,
1995). These prohormone convertases (PC)
 
1
 
 are the mam-
malian homologues of the serine protease subtilisin. Their
expression pattern is either ubiquitous, as for furin (Hat-
suzawa et al., 1990) and PACE4 (Kiefer et al., 1991), or tis-
sue specific, as for PC1 and PC2, which are restricted to
neuroendocrine cells (Seidah et al., 1990, 1991; Smeekens
et al., 1991), or PC4, which is restricted to the testis (Na-
kayama et al., 1992; Seidah et al., 1992). The PCs are syn-
thesized as proenzymes which undergo activation by cleav-
age of the proregion. The role of this propeptide as an
intramolecular chaperone has been established in the case
of subtilisin (Zhu et al., 1989), and the same function has
been proposed for the propeptides of other enzymes of
this family, including the PCs (for review see Siezen et al.,
1995). The removal of the proregion of PC1 (Benjannet et al.,
1993; Zhou and Lindberg, 1993; Lindberg, 1994; Zhou and
Mains, 1994), furin (Molloy et al., 1994; Vey et al., 1994) or
PC5 (DeBie et al., 1996), occurs in the ER shortly after
synthesis. PC2, however, displays a very different post-
translational processing pattern: it is retained in the ER
much longer than the other PCs studied so far, and it is
converted to mature PC2 in the TGN or in the secretory
granules, and not in the ER (Guest et al., 1992; Benjannet
et al., 1993; Shen et al., 1993; Zhou and Mains, 1994). This
unique maturation pathway is correlated with the specific
association of proPC2 with the neuroendocrine protein
7B2 first shown by Braks and Martens (1994).
7B2 is a secretory protein of 185 amino acids migrating at
27 kD on SDS-PAGE (Martens et al., 1989; Hsi et al., 1982).
The 27-kD form is a precursor protein that is cleaved in
the TGN (Ayoubi et al., 1990; Paquet et al., 1991, 1994)
into two domains. The COOH-terminal domain (residues
155–185) of 7B2 (CT peptide) constitutes a specific inhibi-
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Abbreviations used in this paper
 
: AMC, aminomethylcoumarin; CT pep-
tide, COOH-terminal domain (residues 155–185) of 7B2; PC, prohormone
convertase.
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tor of PC2 activity (Martens et al., 1994; Lindberg et al.,
1995). The region of the CT peptide responsible for this ef-
fect has been identified (Van Horssen et al., 1995), and a
mechanism for the termination of the inhibition has been
proposed (Zhu et al., 1996
 
a
 
). The 21-kD NH
 
2
 
-terminal do-
main binds to PC2 (Zhu and Lindberg, 1995). We have
identified a proline-rich segment of this NH
 
2
 
-terminal do-
main that is responsible for 7B2 binding to proPC2 (Zhu
et al., 1996
 
b
 
). We have already shown that binding of 7B2
to PC2 results in the facilitation of proPC2 maturation and
that the NH
 
2
 
-terminal domain alone can mediate this ef-
fect (Zhu and Lindberg, 1995). We have also demon-
strated that whereas proPC2 secreted from CHO cells
could not be activated, coexpression of 7B2 resulted in the
secretion of activatable proPC2 (Zhu and Lindberg, 1995).
The mechanism of the facilitation of proPC2 maturation
by 7B2, however, remains unknown. Based on coimmuno-
precipitation experiments and on the homology of 7B2
with proteins of the chaperone 60 family, Braks and Mar-
tens (1994) have proposed that 7B2 is a molecular chaper-
one specific for PC2. These authors considered a chaper-
one as a protein that binds to and stabilizes another
protein, which results in the facilitation of its correct fate
in vivo, according to Hendrick and Hartl (1993). This defi-
nition, however, does not refer to a particular function but
envelops such different functions as folding, oligomeric as-
sembly, transport to a subcellular compartment, or switch-
ing between active/inactive conformations (for review see
Hendrick and Hartl, 1993). In the present paper, we refer
to molecular chaperones according to a more specific defi-
nition; i.e., as proteins that interact either transiently with
folding intermediates, which results in the facilitation of
folding, or more stably with unfolded or aggregated forms
of other proteins (for review see Hurtley and Helenius,
1989; Rothman, 1989; Gething and Sambrook, 1992; Hartl,
1996).
7B2 binding to proPC2 can occur in the presence of
brefeldin A, suggesting that the association of the two pro-
teins is initiated in a preGolgi compartment (Benjannet et al.,
1995; Braks et al., 1996). The demonstration of coimmuno-
precipitation of sulfated 7B2 and proPC2 indicate that the
two proteins are still associated in the TGN, before cleav-
age of 7B2 and activation of proPC2 (Benjannet et al.,
1995). Thus, 7B2 and proPC2 are transported together
from the ER to the TGN. The facilitation of proPC2 con-
version by 7B2 in AtT-20 cells could, therefore, result from
the action of 7B2 at different steps of the secretory path-
way: (
 
a
 
) proPC2 folding in the ER, since folding is a limit-
ing step in protein transport to the Golgi (for review see
Lodish, 1988); (
 
b
 
) proPC2 transport from the ER to the
Golgi, as both proteins are transported together within
the secretory pathway; and (
 
c
 
) proPC2 conversion into
mature PC2 in the TGN or in the secretory granules, as we
have shown that 7B2 coexpression is required to obtain ac-
tivatable proPC2 from CHO cell secretion medium (Zhu
and Lindberg, 1995). In the present work, we have studied
the interaction of proPC2 with 7B2 in these compartments
of the secretory pathway by radiolabeling experiments in
AtT-20 cells overexpressing either PC2 alone or PC2 and
7B2. We have also performed subcellular fractionation of
CHO cells that overexpress proPC2 in order to reconsti-
tute the activation of proPC2 in the presence of recombi-
nant 7B2 in vitro. Our data establish that in AtT-20 cells,
7B2 is not involved in proPC2 folding but increases
proPC2 transport to the Golgi. Additionally, using our in
vitro system, we demonstrate that 7B2 is required for the
productive cleavage of the propeptide, i.e., for the genera-
tion of active mature PC2.
 
Materials and Methods
 
Antibodies
 
The antiserum against PC2 (LSU18) was directed against a COOH-termi-
nal peptide of mature PC2. The antiserum against 7B2 (LSU13) was
raised against residues 23–39 of 7B2. We have described the specificity of
these two antisera elsewhere (Zhu and Lindberg, 1995). The monoclonal
antibody MON102 was kindly provided by G. Martens (University of
Nijmegen, Nijmegen, The Netherlands). It was directed against 7B2 amino
acids 128–135 (Van Duijnhoven et al., 1991). The antiserum directed against
BiP/GRP78 was obtained from Santa Cruz Biotechnology Inc. (Santa
Cruz, CA). It was directed against amino acids 24–43 of human BiP. Anti-
serum against calnexin was kindly provided by P. Arvan (Albert Einstein
College of Medicine, New York, NY), and was directed against the 19-
COOH-terminal residues of murine calnexin (Kim et al., 1996).
 
Cell Culture, Site-directed Mutagenesis,
and Transfection
 
All AtT-20 cells were cultured at 37
 
8
 
C in 5% CO
 
2
 
. They were maintained
in DME containing 10% Nuserum (Becton Dickinson, Mountain View,
CA), 2.5% fetal bovine serum (Irvine Scientific, Santa Ana, CA) and the
appropriate selection agents, 200 
 
m
 
g/ml G418 (Life Technologies Inc.,
Gaithersburg, MD) and/or 100 
 
m
 
g/ml hygromycin (Sigma Chemical Co.,
St. Louis, MO). Cells were transfected using Lipofectin (Life Technolo-
gies) as described (Zhu and Lindberg, 1995). The parental AtT-20 cells
and those stably expressing PC2 were kindly provided by R. Mains (Johns
Hopkins University School of Medicine, Baltimore, MD) (Zhou and
Mains, 1994). The transfection of AtT-20/PC2 cells with a plasmid encod-
ing rat 27-kD 7B2 has already been described (Zhu and Lindberg, 1995).
The experiments in which we compared the kinetics of proPC2 matura-
tion were performed with three different clones expressing 7B2 and PC2,
using the parental cells as well as a transfected clone that did not overex-
press 7B2 as controls. To obtain cell lines that expressed the 27-kD 7B2
and mutated proPC2, AtT-20 cells were first transfected with a pCEP4
plasmid (Invitrogen, Carlsbad, CA) encoding rat 27-kD 7B2. A high-express-
ing clone was selected and supertransfected with a plasmid pRC/CMV
(Invitrogen) encoding PC2 mutated at the three glycosylation sites. The
Asn of each glycosylation site was replaced by a Gln. This mutation was
obtained by polymerase chain reaction-mediated methods already de-
scribed (Zhu and Lindberg, 1995). The primers used were: 5
 
9
 
-GGGC-
CAAGCTTCACTCCCAAAGAAGGATGG-3
 
9
 
, 5
 
9
 
-GCCATACAAGTC-
TGTGGTAG-3
 
9
 
, 5
 
9
 
-CTACCACAGACTTGTATGGCCAATGTACTC-
TGAGACACTCTGG-3
 
9
 
, 5
 
9
 
-CGCGCTCTAGAGTGAAGGCGGAAGC-
GTGGCC-3
 
9
 
, 5
 
9
 
-AGGTCTCCTCTCCTGGTCGCTTGGACTGTGATG-
ACAGCTTGGA-3
 
9
 
, 5
 
9
 
-GACCAGGAGAGGAGACCTGAACATCCA-
AATGACCTCCCCAATGGGC-3
 
9
 
. The study of the effect of this muta-
tion was performed on two different clones.
The CHO cells stably expressing proPC2 that we used for the subcellu-
lar fractionation studies have already been described (Shen et al., 1993).
This cell line was amplified for the expression of proPC2 using the dihy-
drofolate reductase method, but did not produce active enzyme.
 
Metabolic Labeling, Protein Extraction,
and Immunoprecipitation
 
5 
 
3
 
 10
 
5
 
 AtT-20 cells were labeled 40–48 h after seeding in six-well plates.
They were labeled with 500 
 
m
 
Ci/ml of [
 
35
 
S]methionine and cysteine (Pro-
mix; Amersham Corp., Arlington Heights, IL) for 10 min. After the pulse,
they were extracted or chased in DME containing 2% fetal bovine serum.
The sulfate-labeling experiments were performed in 12-well plates. Cells
were labeled with 2 mCi/ml [
 
35
 
S]sulfate (ICN Biomedicals, Inc., Irvine,
CA) for 15 min and chased as previously described. In some experiments,
cells were treated with 5 mM DTT during the pulse and the chase. They
were then washed twice with PBS before a further chase without DTT. To 
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prevent the acidification of the pH in the TGN and the secretory granules,
cells were incubated with 1 
 
m
 
M bafilomycin A1 (Kamiya Biomedical Co.,
Seattle, WA) during the chase.
Before extraction, cells were treated with 1 ml of 0.2 M iodoacetamide
in PBS for 10 min on ice. All of the following steps of extraction and im-
munoprecipitation were performed at 4
 
8
 
C. For immunoprecipitation con-
ducted under native conditions, proteins were extracted with a buffer con-
taining 1% Triton X-100 in 25 mM Tris-HCl, pH 7.4, 100 mM NaCl, 10
mM iodoacetamide, 5 mM EDTA and 0.5 mM 
 
p
 
-chloromercuriphenylsul-
fonic acid (Sigma Chemical Co.) and 1 mM phenylmethanesulfonyl fluo-
ride (Boehringer Mannheim Corp., Indianapolis, IN). The extracts were
centrifuged for 10 min at 15,000 
 
g.
 
 Supernatants were diluted to 0.5% Tri-
ton X-100 and stored at 
 
2
 
20
 
8
 
C before immunoprecipitation. For immuno-
precipitation under denaturing conditions, proteins were extracted as pre-
viously described (Zhu and Lindberg, 1995).
Extracts were first incubated for 1 h in the presence of protein A cou-
pled to Sepharose CL-4B (Pharmacia Biotech. Inc., Piscataway, NJ). The
supernatants were then incubated for 4 h or overnight in the presence of
antisera directed against either PC2 or 7B2. To immunoprecipitate BiP/
GRP78-bound PC2, BiP/GRP78 was first immunoprecipitated under na-
tive conditions for 2 h. The immune complexes were boiled in 1% SDS for
5 min before dilution in immunoprecipitation buffer and PC2 immunopre-
cipitation. The immune complexes were precipitated with protein A cou-
pled to Sepharose CL-4B and washed once with immunoprecipitation
buffer, once with 0.5 M NaCl in PBS, and twice with PBS. They were then
boiled in Laemmli sample buffer before separation by SDS-PAGE on 8.8
or 12% acrylamide gels. Gels were either treated for fluorography with
Amplify (Amersham Corp.) or directly exposed to a phosphoscreen and
analyzed with a phosphorimager (Storm; Molecular Dynamics, Sunnyvale,
CA) and ImageQuant software (Molecular Dynamics).
 
Glycosidase Digestions
 
Immunoprecipitated PC2 was boiled in 2% SDS in 10 mM Tris, pH 7.4,
for 5 min and diluted in the digestion buffer. Endoglycosidase H digestion
was performed in 100 mM sodium acetate, pH 5.5, in the presence of
10 mU/ml endoglycosidase H (Boehringer Mannheim Corp.). 
 
N
 
-glycanase
F digestion was performed in 100 mM sodium phosphate, pH 7.4, contain-
ing 0.5% Nonidet-P40 in the presence of 4 U/ml 
 
N
 
-glycanase F (Boeh-
ringer Mannheim Corp.). Control digestions were performed with either
of these buffers without enzyme. Incubations were conducted overnight at
37
 
8
 
C. They were stopped by addition of Laemmli sample buffer and
boiled 5 min before separation by SDS-PAGE. Digestion of PC2 with
 
N
 
-glycanase F under native conditions was performed directly after PC2
immunoprecipitation. The incubations were conducted in the presence of
8 U/ml enzyme at 37
 
8
 
C for 30–120 min, with either time period providing
the same results.
 
Sucrose Gradient Centrifugation
 
We investigated PC2 aggregation in the ER by sucrose gradient centrifu-
gation according to Simons and collaborators (1995). Briefly, AtT-20 cells
were radiolabeled and proteins were extracted as described previously for
native immunoprecipitation and loaded on the top of a continuous sucrose
gradient (10–40%) containing 0.1% Triton X-100. The gradients were
centrifuged for 7 h at 4
 
8
 
C in a rotor (SW50.1; Beckman Instrs., Fullerton,
CA) at 45,000 rpm. PC2 was immunoprecipitated from the fractions and
separated by SDS-PAGE. The radioactivity of the gels was analyzed with
a phosphorimager.
 
Subcellular Fractionation and Marker Assays
 
CHO/PC2 cells were grown in four 850 cm
 
2
 
 rollers for each membrane
preparation. Rollers were washed with calcium-free PBS on ice. All of the
following steps were performed at 4
 
8
 
C. Cells were scraped in calcium-free
PBS and pelleted. They were resuspended in 0.25 M sucrose in 10 mM
Tris, pH 7.4, and homogenized with a stainless steel ball-bearing homoge-
nizer. The homogenate was centrifuged for 20 min at 7,500 
 
g.
 
 The super-
natant was pelleted at 56,000 rpm in a rotor (TL 100.4; Beckman Instrs.)
for 35 min. Pellets were resuspended in 1.15 M sucrose and loaded on the
bottom of a discontinuous sucrose gradient composed of 1.5 ml of 0.86 M
sucrose and 1.5 ml of 0.25 M sucrose. The gradient was centrifuged at
46,000 rpm in a rotor (TL 100.4; Beckman Instrs.) for 140 min. Five frac-
tions were collected.
Galactosyl transferase activity was used as a marker for the Golgi
membranes. The activity was measured according to Chaney et al. (1989),
using [
 
3
 
H]UDP-galactose as a substrate (Amersham Corp.). The molecu-
lar chaperone BiP/GRP78 was used as a marker for the ER. The content
of each fraction was assayed by immunoblotting.
 
Immunoblotting
 
Proteins were separated by SDS-PAGE on 8.8% gels. They were then
transferred to nitrocellulose membranes that were incubated with antisera
as described previously (Shen et al., 1993). Alkaline phosphatase activity
was detected using either nitroblue tetrazolium and 5-bromo-4chloro-
3indolyl phosphate as substrate or the Vistra Western blot substrate (Am-
ersham Corp.). Membranes were analyzed with a phosphorimager (Storm;
Molecular Dynamics) and quantitation of the results was performed with
ImageQuant software (Molecular Dynamics).
 
Enzyme Assays
 
PC2 activity was measured using 200 
 
m
 
M Pyr-Glu-Arg-Thr-Lys-Arg-ami-
nomethylcoumarin (AMC) as a substrate as previously described (La-
mango et al., 1996). The assay was performed in 100 mM sodium acetate,
pH 5, containing 5 mM CaCl
 
2
 
, 1% Triton X-100 in the presence of a pro-
tease inhibitor cocktail composed of 1 
 
m
 
M pepstatin, 0.28 mM tosylpheny-
lalanine chloromethyl ketone (TPCK), 1 
 
m
 
M 
 
trans
 
-epoxysuccinic acid
(E64), and 0.14 mM tosyllysyl chloromethyl ketone (TLCK). All incuba-
tions were conducted at 37
 
8
 
C for time points ranging from 30 min to 4 h.
In some experiments, the activity was also measured in the presence of 1 
 
m
 
M
7B2 CT peptide, a specific inhibitor of PC2 activity (Lindberg et al., 1995).
The activity was measured in triplicate and assays were reproduced with
three different subcellular fraction preparations. Fluorescence of AMC was
measured with a fluorometer (Cambridge Technology, Inc., Cambridge,
MA). The amount of released product was calculated by reference to the
fluorescence of free AMC standard.
 
Results
 
7B2 Is Secreted More Slowly Than 7B2 Due to Its 
Slower Transport to the TGN
 
Kinetic studies of the release of newly synthesized 7B2
and PC2 show that 7B2 is secreted more rapidly than PC2
when both proteins are stably coexpressed in AtT-20 cells
(Zhu and Lindberg, 1995; Table I). In constitutively-
secreting cells, the limiting factor in the secretion of pro-
teins is the time required for their folding in the ER (for
review see Lodish, 1988), but in neuroendocrine cells, dif-
ferent kinetics of secretion can also be indicative of differ-
ences in sorting at the exit from the TGN (for review see
Kelly, 1985). To distinguish between these two possibili-
ties, we studied the release of sulfated PC2 and 7B2, as sul-
fation is a posttranslational modification that specifically
takes place in the 
 
trans
 
-Golgi (Baeuerle and Huttner,
1987). Sulfated 7B2 and PC2 were released at the same
rate into the medium (Table I). The difference between the
release of newly synthesized and sulfated 7B2 and PC2 in-
dicates, therefore, that the limiting step of proPC2 secre-
tion is the exit from the ER. On the other hand, newly syn-
thesized 7B2 exits from this compartment more rapidly
than PC2. This is in agreement with the difference in half-
life between 7B2 and proPC2, which are both cleaved in
the TGN/secretory granules: the 7B2 precursor half-life is
15 min, whereas the proPC2 half-life is 
 
z
 
100 min in AtT-
20 cells that overexpress both proteins (Zhu and Lindberg,
1995). This result is also consistent with the long retention
of proPC2 in the ER already described in different cell
models (Guest et al., 1992; Benjannet et al., 1993; Shen et
al., 1993; Zhou and Mains, 1994), and with the subcellular
localization of PC2 in transfected AtT-20 cells (Mains et al., 
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1995; Creemers et al, 1996), and in anterior pituitary lac-
totrophs (Muller et al., 1997).
 
Newly Synthesized 7B2 and ProPC2 Do Not Acquire 
Binding Capacity at the Same Rate
 
Previous studies have proposed that the binding of 7B2 to
proPC2 occurs in the ER (Benjannet et al., 1995; Braks et al.,
1996) and that the two proteins are transported as a com-
plex from the ER to the 
 
trans
 
-Golgi (Benjannet et al., 1995).
According to this hypothesis, 7B2 and proPC2 should exit
from the ER at the same rate. This is in apparent contra-
diction with the differences in transport from the ER to
the TGN that we have described above. Both hypotheses
could be reconciled if 7B2 and proPC2 did not acquire the
capacity to bind each other at the same rate before they
exit the ER, i.e., if 7B2 could bind PC2 rapidly after syn-
thesis, but proPC2 required a longer time before it could
bind 7B2. To determine if this is the case, we studied the
kinetics of association of 7B2 and proPC2. The same radi-
olabeled cell extracts were immunoprecipitated with anti-
sera directed against either 7B2 or PC2 (Fig. 1). The antise-
rum directed against 7B2 could not coimmunoprecipitate
proPC2 at the end of the pulse. Coimmunoprecipitation of
proPC2 required a further chase and was time dependent
(Fig. 1). This result implied that newly synthesized proPC2
only gradually acquires the capacity to bind 7B2. This dif-
ferent pattern of coimmunoprecipitation at the end of the
pulse and 30 min later could also be caused by a masking
of the 7B2 epitope recognized by the antiserum, i.e., resi-
dues 23–39, at early time points of the chase. This was
ruled out by reproducing these results with the mono-
clonal antibody MON102 directed against amino acids 128
to 135 (Van Duijnhoven et al., 1991), which are located in
the COOH-terminal region of the 21-kD fragment of 7B2
(not shown). Immunoblotting PC2 in the immunoprecipi-
tates obtained with antisera directed against 7B2 showed
that even though there was no radiolabeled proPC2 immu-
noprecipitated at the end of the pulse, the 7B2 antiserum
did coimmunoprecipitate unlabeled proPC2 (not shown).
After chases 
 
.
 
60 min, the study of proPC2 coimmunopre-
cipitated by anti–7B2 antiserum was biased by the conver-
sion of proPC2 into PC2. Results obtained under experi-
mental conditions that prevented proPC2 conversion (see
Fig. 6 
 
a
 
), however, demonstrated that the amount of
proPC2 coimmunoprecipitated by the antiserum directed
against 7B2 continues to increase beyond 60 min (see Fig. 8).
Unlike the 7B2 antiserum, the antiserum directed against
proPC2 could coimmunoprecipitate radiolabeled 7B2 im-
mediately after the pulse (Fig. 1). This result implied that,
unlike PC2, newly synthesized 7B2 acquires proPC2 bind-
ing capacity very soon after synthesis. The amount of 7B2
coimmunoprecipitated did not increase with time (Fig. 1).
The PC2 antiserum could coimmunoprecipitate about the
same amount of 27-kD 7B2 at the end of the pulse as 21-kD
7B2 30 min later. This demonstrated that the cleavage of
7B2 does not affect its association with proPC2.
The experiments presented in Fig. 1 also show that 7B2
is cleaved with the same kinetics whether it is bound to
proPC2 or not. Cleavage of 7B2 is a marker for 7B2 trans-
port from the ER to the 
 
trans
 
-Golgi, as it occurs after sul-
fation (Paquet et al., 1994). Therefore, proPC2-bound 7B2
is transported to the TGN at the same rate as total 7B2
(Fig. 1). We also observed the same kinetics of processing
of 7B2 in AtT-20 cells expressing 7B2 in the absence of
proPC2 (results not shown). Therefore, binding of proPC2
has no effect on 7B2 transport kinetics to the TGN. Taken
together, these data support the idea that newly synthe-
sized 7B2 binds only to unlabeled proPC2 synthesized be-
fore the pulse and accumulated in the ER, and that 7B2 ex-
its this compartment sooner after synthesis than proPC2.
Thus, proPC2 requires a longer time period in the ER en-
vironment before it can bind to 7B2. This suggested that
proPC2 must fold before it can bind to 7B2, whereas 7B2
folding is apparently not a limiting step in the formation of
the complex.
 
7B2 Is Not Involved in ProPC2 Folding
 
To investigate the chaperone activity of 7B2 on proPC2
folding, several strategies were attempted to establish a
proPC2 folding assay. First we used digestion of immuno-
precipitated proPC2 by 
 
N
 
-glycanase F under native condi-
tions to study proPC2 conformational changes (Fig. 2).
The rationale of this experiment is that the conformation
changes that occur during folding modify the access of the
 
Table I. Secretion of Newly Synthesized and Sulfated 7B2
and ProPC2
 
Time
Percent secreted
30 min 60 min
 
min
 
Methionine 7B2 10 27
PC2 0.3 15
Sulfate 7B2 29 —
PC2 31 —
 
AtT-20 cells were labeled for 10 min with [
 
35
 
S]methionine and cystine (
 
Methionine
 
),
or for 15 min with [
 
35
 
S]sulfate (
 
Sulfate
 
). They were then chased for the indicated time
periods. 7B2 and PC2 were immunoprecipitated and separated by SDS-PAGE. The
radioactivity in the gels was analyzed with a phosphorimager. The percent of 7B2
and PC2 released per total labeled 7B2 and PC2, respectively, was calculated in du-
plicate and the experiments were reproduced twice.
Figure 1. 7B2 and PC2 do not acquire the capacity to bind each
other at the same rate. AtT-20 cells that express 7B2 and PC2 were
labeled for 10 min and chased for the indicated time periods. 7B2
and PC2 were coimmunoprecipitated under native conditions us-
ing antisera directed against 7B2 and PC2 as indicated. 21 kD in-
dicates the position of the 21-kD NH2-terminal domain of 7B2
and 27 kD indicates the position of the whole 7B2 precursor. 
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enzyme to its substrate (Feng et al., 1995). Indeed, when
cells were extracted at the end of the pulse, 
 
N
 
-glycanase
F-digested proPC2 migrated as three bands. When cells
were extracted after a 30-min chase, the band that mi-
grated most rapidly was no longer present. We observed
the same difference whether cells expressed PC2 alone or
with 7B2 (Fig. 2). This indicated that proPC2 undergoes
the same conformational changes whether 7B2 is coex-
pressed or not, and supported the idea that 7B2 is not in-
volved in early proPC2 folding events.
Secondly, we studied proPC2 migration during SDS-
PAGE under reducing and nonreducing conditions. PC2
contains eight cysteines, six of which are present in the cat-
alytic domain and are conserved in the other PCs. Model-
ling of the catalytic domain based on the subtilisin and ther-
mitase structure has resulted in the identification of two
disulfide bridges (Siezen et al., 1994). ProPC2, however,
showed a very small molecular weight shift after separa-
tion by SDS-PAGE under reducing or nonreducing condi-
tions. This strategy, therefore, did not permit the observa-
tion of folding intermediates. We did not observe the
presence of any disulfide-linked aggregates whether 7B2
was coexpressed with PC2 or not. Thirdly, we investigated
the noncovalent aggregation of proPC2 by sucrose gradi-
ent centrifugation of cell extracts (Simons et al., 1995) and
did not observe any significant difference in the distribu-
tion of proPC2 on the gradient whether the cells expressed
7B2 or not (not shown).
Fourthly, we investigated the binding of proPC2 to the
molecular chaperones calnexin and BiP/GRP78. These mo-
lecular chaperones are localized in the ER where they bind
to unfolded proteins and folding intermediates (Gething
and Sambrook, 1992; Ou et al., 1993). If 7B2 were a chap-
erone involved in proPC2 folding, we might expect that its
coexpression with PC2 should modify the pattern of asso-
ciation of proPC2 with other chaperones, as folding inter-
mediates sequentially bind to molecular chaperones. ProPC2
binding to calnexin was very low: 5% of the total radio-
labeled proPC2 could be coimmunoprecipitated by the
calnexin antiserum at the end of the pulse, and it was hardly
detected after a 30-min chase (Fig. 3). Coexpression of 7B2
did not modify proPC2 coimmunoprecipitation with cal-
nexin. Binding of proPC2 to BiP was lower than to cal-
nexin; it did not change with time (see Fig. 5 
 
a
 
) and was
not affected by 7B2 coexpression.
 
ProPC2 Must Fold Before It Can Bind 7B2
 
To provide more direct evidence for the requirement of
proPC2 folding before 7B2 binding, we studied the effect
of the prevention of proPC2 folding on 7B2 binding. Pro-
PC2 folding was impaired using two different approaches:
treatment of the cells with DTT, and mutation of PC2 gly-
cosylation sites.
DTT treatment prevents the formation of disulfides in
newly synthesized proteins (Braakman et al., 1992) but
does not affect the secretory pathway (Lodish and Kong,
1993). In AtT-20 cells treated with DTT, proPC2 conver-
sion into PC2 was inhibited (Fig. 4 
 
a
 
). ProPC2 was not se-
creted, but was degraded within the cells. On the other
hand, DTT had no effect on the cleavage nor the secretion
of 7B2 (Fig. 4 
 
b
 
). When cells were incubated 30 min in the
presence of DTT, the binding of proPC2 to 7B2 was inhib-
ited (Fig. 4 
 
c
 
). 7B2 binding was restored, however, 30 min
after the washout of DTT from the medium (Fig. 4 
 
c
 
).
Therefore, formation of the disulfide bridges is required
before association of 7B2 with proPC2.
To more specifically prevent proPC2 folding, we mu-
tated its three 
 
N
 
-glycosylation sites. The involvement of
core-glycosylation in the folding of proteins in the ER has
been proposed and mutation of the glycosylation sites of
some secreted proteins results in their misfolding (for re-
view see Helenius, 1994). The unfolded state of the ungly-
cosylated proPC2 was demonstrated by its increased bind-
ing to the molecular chaperone BiP/GRP78 (Fig. 5 
 
a
 
), which
binds to unfolded proteins and folding intermediates (Geth-
Figure 2. 7B2 does not mod-
ify the pattern of digestion of
native proPC2 by N-glyca-
nase F. AtT-20 cells that ex-
press PC2 alone or also 7B2
were labeled for 10 min and
directly extracted or chased
for 30 min before extraction.
ProPC2 was immunoprecipi-
tated under native conditions
and digested with N-glyca-
nase F as described in Mate-
rials and Methods. The reac-
tion was stopped by addition
of Laemmli sample buffer
and boiled for 5 min before
separation of proteins by
SDS-PAGE.
Figure 3. 7B2 does not mod-
ify the association of proPC2
with calnexin. AtT-20 cells
that express PC2 alone (A/P)
or also 7B2 (A/P/7) were
labeled for 10 min and directly extracted or chased for 30 min be-
fore extraction. Calnexin was immunoprecipitated under native
conditions. The immune complexes were boiled in 1% SDS for 5
min. They were then diluted in immunoprecipitation buffer and
PC2 was immunoprecipitated. 
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ing and Sambrook, 1992). Mutant proPC2 binding to BiP
was stable over a 30-min chase (Fig. 5 
 
a
 
). This mutant did
not bind to calnexin, which is in agreement with the lectin
binding capacity of this chaperone (Ou et al., 1993). Ungly-
cosylated proPC2 did not form more aggregates in the ER
than wild-type proPC2, as assayed by centrifugation on
10–40% sucrose gradient (not shown). The unglycosylated
mutant proPC2 could not be converted to mature PC2
(Fig. 5 
 
b
 
). Two bands of approximately the same mol wt
are present in the mutant lane (
 
3NQ
 
); the lower one corre-
sponds to unglycosylated proPC2 and the upper one corre-
sponds to BiP, as the immunoprecipitation was done under
native conditions. Mutated proPC2 was not released in the
medium but was degraded in the cells. This unfolded mutant
form of proPC2 was also unable to bind 7B2 (Fig. 5 
 
c
 
).
Figure 4. Effect of DTT on proPC2 and
7B2 maturation and binding. AtT-20 cells
that express 7B2 and PC2 were labeled for
10 min and chased for the indicated time
periods. Cells treated with 5 mM DTT
were in the continuous presence of the
drug during the pulse and the chase. (a)
DTT prevents proPC2 processing and se-
cretion. Cells were extracted at the end of
the pulse and after a 2-h chase. PC2 was
immunoprecipitated from the cell extracts (Cells) and from the media (M) under denaturing conditions. (b) DTT does not affect 7B2
processing and secretion. Cells were extracted at the end of the pulse and after a 30-min chase. 7B2 was immunoprecipitated from the
cell extracts and from the media under native conditions. (c) DTT reversibly prevents 7B2 binding to proPC2. Cells were first chased in
the presence or absence of DTT for 30 min. Cells that had been incubated in the presence of DTT were then washed twice with PBS and
further chased for 30 min in the presence or absence of DTT. 7B2 was immunoprecipitated under native conditions.
Figure 5. Mutation of proPC2 glycosylation sites prevents 7B2
binding. AtT-20 cells that express 7B2 and either wild-type PC2
(WT) or unglycosylated PC2 (3NQ) were labeled for 10 min and
chased for the indicated times. (a) Unglycosylated proPC2 stably
binds to BiP. BiP/GRP78 was immunoprecipitated under native
conditions at the end of the labeling period and after a 30-min
chase. The immune complexes were solubilized in 1% SDS at
1008C. They were then diluted in the immunoprecipitation buffer
and PC2 was immunoprecipitated. The asterisk indicates the po-
sition of unglycosylated proPC2. (b) Unglycosylated proPC2 is
neither processed nor secreted. Cells were extracted at the end of
the pulse and after a 120-min chase. PC2 was immunoprecipitated
under native conditions from the cell extracts and from the me-
dia. The asterisk indicate the position of unglycosylated proPC2.
(c) Unglycosylated proPC2 does not bind 7B2. 7B2 was immuno-
precipitated under native conditions from the extracts of cells
that had been chased for 30 min.
Taken together, these experiments demonstrate that pre-
vention of the folding of proPC2 results in the loss of 7B2
binding capacity and, thus, that proPC2 must fold before it
can bind 7B2. These data are in agreement with the lack of
involvement of 7B2 in the early steps of proPC2 folding.
7B2 Increases the Transport Rate of ProPC2 from the 
ER to the Golgi
We have already shown that the half-life for the conver-
sion of proPC2 decreases considerably in the presence of
7B2 (Zhu and Lindberg, 1995). The results presented above
supported the notion that this effect is not mediated by an
increase in the proPC2 folding rate. Thus, 7B2 could act by
increasing either the rate of transport, or the rate of pro-
peptide cleavage, or both. To study proPC2 transport to
the Golgi apparatus, we investigated the acquisition of en-
doglycosidase H resistance. It should be noted that be-
cause of carbohydrate heterogeneity, PC2 never becomes
completely resistant to endoglycosidase H digestion. The
demonstration of the presence of an endoglycosidase
H-resistant form of proPC2/PC2 requires, therefore, a
control N-glycanase F digestion (Bennett et al., 1992).
Even after release into the medium, only one or two of the
three potential glycosylation sites have acquired endogly-
cosidase H resistance, whereas the others remain sensitive
(Mains et al., 1995; Creemers et al., 1996). As the goal of
this experiment was to differentiate between 7B2 effects
on the transport of proPC2 and on its conversion into PC2,
we needed to work under experimental conditions that
prevent the cleavage of the PC2 propeptide. This was nec-
essary since previous studies have shown that the conver-
sion of proPC2 into PC2 is very closely related in time to
the acquisition of endoglycosidase H-resistance: i.e., these
studies could not identify any proPC2 partially resistant to
endoglycosidase H nor any mature PC2 completely sensi-
tive to endoglycosidase H (Mains et al., 1995; Creemers et al.,
1996; Muller, L., and I. Lindberg, unpublished results).
ProPC2 conversion requires an acidic pH, which corre-
sponds to the TGN and the secretory granules (Shennan
et al., 1995; Lamango et al., 1996). To block proPC2 cleav-
age, we prevented the acidification of the pH in these in-
tracellular compartments with bafilomycin A1 treatment.
Bafilomycin A1 is a specific inhibitor of the vacuolar H1-
ATPase responsible for the acidification of pH in the TGN
and secretory granules (Bowman et al., 1988). This treat-
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cells that express proPC2 alone and exhibit a low rate of
conversion, as well as in cells that coexpress PC2 and 7B2
and, therefore, possess a much higher rate of processing
(Fig. 6 a). This drug did not affect 7B2 cleavage (Fig. 6 b),
which is in agreement with the proposed cleavage of 7B2
by furin (Paquet et al., 1994), an enzyme active at neutral
pH (Bresnahan et al., 1990; Hatsuzawa et al., 1992; Molloy
et al., 1992). Bafilomycin A1 had no effect on the binding
of 7B2 to proPC2 (Fig. 6 b). It also did not prevent proPC2
transport from the ER to the Golgi, as demonstrated by
the acquisition of endoglycosidase H resistance (Fig. 6 c).
After a 2-h chase in the presence of bafilomycin A1, en-
doglycosidase H–digested PC2 migrated as a doublet
(Fig. 6 c). The lower band comigrated with N-glycanase
F-digested PC2 and, therefore, corresponded to endogly-
cosidase H–sensitive PC2. The upper band corresponded
to PC2 partially resistant to endoglycosidase H. This result
demonstrated that some of the newly synthesized PC2 had
acquired complex carbohydrates in the Golgi in the pres-
ence of bafilomycin A1. This is in agreement with previous
studies that have shown that bafilomycin A1 does not im-
pede intracellular transport to the Golgi, but only between
the TGN and the plasma membrane (Umata et al., 1990;
Yoshimori et al., 1991).
These experimental conditions allowed us to study the
effect of 7B2 on proPC2 transport to the Golgi. Cells ex-
pressing PC2 alone or PC2 and 7B2 were treated with ba-
filomycin A1. ProPC2 was immunoprecipitated, dena-
tured, and digested with endoglycosidase H. Fig. 7 shows
that the coexpression of 7B2 with PC2 increased proPC2
acquisition of endoglycosidase H resistance. Acquisition
of endoglycosidase H resistance was very low (z20% after
120 min) in cells that express PC2 alone, in agreement with
the low maturation rate of proPC2 in these cells (Fig. 6 a)
(Mains et al., 1995; Zhu and Lindberg, 1995). Coexpression
of 7B2 increased the level of endoglycosidase H–resistant
PC2 to z65% after a 120-min chase. The kinetics of acqui-
sition of endoglycosidase H resistance paralleled those of
proPC2 maturation that we have already described in
these cells (Fig. 6 a; Zhu and Lindberg, 1995).
We also investigated the kinetics of acquisition of en-
doglycosidase H resistance of 7B2-bound proPC2 (Fig. 8).
ProPC2 was coimmunoprecipitated under native condi-
tions with the antiserum directed against 7B2, and dena-
tured before digestion with endoglycosidase H. After a
30-min chase, 7B2-bound proPC2 migrated as a faint dou-
blet corresponding to equal amounts of endoglycosidase
H–sensitive and –resistant proPC2s. If the 7B2–proPC2
complexes were accumulated in the ER, the endoglycosi-
dase H-sensitive 7B2-bound proPC2 should increase with
time. If, on the other hand, the 7B2–proPC2 complexes
were transported to the Golgi rapidly after their forma-
tion, the endoglycosidase H-resistant 7B2-bound proPC2
should increase. The data in Fig. 8 support the latter hy-
pothesis. Indeed, the endoglycosidase H–resistant 7B2-
bound proPC2 (Fig. 8) increased with time in parallel with
the endoglycosidase H–resistant total PC2 immunoprecip-
itated with the PC2 antiserum (Fig. 8). This strongly sug-
gests that the effect observed in Fig. 7 was mediated by the
binding of proPC2 to 7B2. This result also demonstrates
that proPC2 binds 7B2 in the ER and is then rapidly trans-
ported in the Golgi apparatus where it acquires complex
oligosaccharides. Thus, the facilitation of proPC2 conver-
sion by 7B2 occurs at least in part through an increase of
its transport from the ER to the Golgi.
7B2 Induces the Conversion and the Activation of 
ProPC2 from Golgi-enriched Subcellular Fractions
We have already shown that the coexpression of PC2 with
the 21-kD NH2-terminal domain of 7B2 is required for the
production of activatable proPC2 by CHO cells (Zhu and
Lindberg, 1995). To study this requirement, we reconsti-
tuted proPC2 activation by adding recombinant 7B2 to
subcellular fractions from CHO cells that express proPC2
alone. This system allowed us to study in vitro the effect of
7B2 on both the maturation and the activity of PC2.
The homogenate was first centrifuged at 7,500 g for 20
Figure 6. Bafilomycin A1 effect on proPC2 and 7B2 maturation
and binding. (a) Bafilomycin A1 prevents the removal of the
proPC2 propeptide. AtT-20 cells that express proPC2 alone or
proPC2 and 7B2 were labeled for 10 min and directly extracted
or chased for 120 min before extraction in the presence or ab-
sence of 1 mM bafilomycin A1. PC2 was immunoprecipitated. (b)
Bafilomycin A1 does not affect 7B2 cleavage and binding to pro-
PC2. AtT-20 cells that express 7B2 and PC2 were labeled for 10
min and directly extracted or chased for 30 min before extraction.
7B2 was immunoprecipitated under native conditions. (c) Bafilo-
mycin A1 does not inhibit transport to the Golgi. AtT-20 cells
that express 7B2 and PC2 were labeled for 10 min and chased for
120 min before extraction. PC2 was immunoprecipitated, dena-
tured, and digested under control conditions (C) or with endogly-
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min. The supernatant (S1) was pelleted and the pellet sep-
arated by flotation on a sucrose gradient. We characterized
the Golgi fraction using galactosyl transferase activity as a
marker and the ER fraction using BiP/GRP78 as a marker
(Table II). The Golgi fraction contained a small quantity
of BiP which could be relevant to a small amount of con-
tamination by ER membranes as well as to the cycling of
BiP between the cis-Golgi and the ER (for review see Pel-
ham, 1991; Hammond and Helenius, 1994). The proPC2
content of these fractions was quantitated by immunoblot-
ting (Table II), using proPC2 purified from CHO cell me-
dium as a standard (Lamango et al., 1996). ProPC2 was
slightly more concentrated in the Golgi membranes, but
the total content was higher in the ER fraction.
We analyzed the molecular forms of PC2 present in each
fraction after an incubation at 378C at pH 5 in the presence
of 5 mM calcium. In the absence of recombinant 21-kD
7B2, proPC2 was detected in the three fractions, and a
very small amount of the 71- and the 66-kD PC2 forms
could also be detected in the Golgi fraction (Fig. 9 a). When
recombinant 21-kD 7B2 was added, proPC2 was con-
verted into mature PC2 only in the Golgi fraction. This
was not accompanied by any increase of the 71-kD form.
There was no detectable mature PC2 in the S1 and ER
fractions. PC2 activity was measured by incubating mem-
branes under the same conditions using Pyr-Glu-Arg-Thr-
Lys-Arg-AMC as a substrate. The activity was measured
with 1 mg of total protein, and results were normalized to
the proPC2 content of each fraction (Fig. 9 b). No signifi-
cant activity could be detected in any fraction in the ab-
sence of recombinant 21-kD 7B2, even in the Golgi frac-
tion where a very small amount of 66-kD PC2 was detected
by immunoblotting. However, 7B2 could induce enzyme ac-
tivity in the different fractions, even in the S1 and ER, in
which we could not detect mature PC2 by immunoblot-
ting. The activity was highly enriched in the Golgi fraction
compared to the S1 fraction, and very low in the ER frac-
tion. When ER and Golgi fractions were mixed and the
amount of total proteins doubled, the activity detected was
inhibited by z35% as compared with Golgi membranes
alone (not shown). This result potentially implied the pres-
ence of an inhibitory factor in the ER fraction. This inhibi-
tion was not detected if the Golgi membranes were preac-
tivated at an acidic pH at 378C in the presence of calcium,
thus indicating that it is the activation of proPC2 that is in-
hibited and not PC2 activity. Indeed, immunoblotting the
mixed membranes showed that proPC2 conversion was
partially inhibited (not shown). Conversion of proPC2 in
the ER fraction could not be detected, and total PC2 activ-
ity in the ER fraction was only 10% of the total Golgi PC2
activity. Thus, even if the amount of proPC2 contained in
the ER fraction and activated in the presence of 7B2 is un-
derestimated due to the presence of an inhibitory factor,
the main source of activatable proPC2 is the Golgi fraction.
When membranes were incubated in the absence of de-
tergent, proPC2 could be cleaved but the activity detected
was inhibited by 75% (not shown). This indicated that the
activity is located within membrane-bound compartments.
The identity of this activity as PC2 was demonstrated by
its complete inhibition by the 7B2 CT peptide (Fig. 9 b), a
PC2-specific inhibitor (Lindberg et al., 1995). This peptide
could not, however, prevent proPC2 conversion in Golgi
membranes (Fig. 9 a). As a control, we also performed the
same experiments with CHO cells that do not overexpress
PC2. Recombinant 21-kD 7B2 could not induce enzyme
activity in any subcellular fraction from these cells (data
Figure 7. 7B2 increases
proPC2 transport to the
Golgi. AtT-20 cells express-
ing PC2 alone or PC2 and
7B2 were labeled for 10 min
and chased for the indicated
time periods in the presence
of 1 mM bafilomycin A1. PC2
was immunoprecipitated, de-
natured, and digested with
endoglycosidase H. r indicates
the position of endoglycosi-
dase H–resistant proPC2, and
s the position of endoglycosi-
dase H–sensitive proPC2.
Figure 8. The 7B2-proPC2
complex is not accumulated
in the ER but rapidly trans-
ported to the Golgi. AtT-20
cells expressing PC2 and
7B2 were labeled for 10 min
and chased for the indicated
times in the presence of 1 mM
bafilomycin A1. PC2 and 7B2
were immunoprecipitated un-
der native conditions, dena-
tured, and digested with en-
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not shown), thus confirming that the activity measured
corresponds to PC2 and not to an activity endogenous to
CHO cell Golgi membranes or to lysosomal contamination.
7B2-induced Activation of PC2 is pH and
Calcium dependent
We investigated the pH dependency of proPC2 conversion
and PC2 activity measurable in the presence of 7B2 in the
Golgi fraction. ProPC2 maturation was maximal at pH 5.
It was much lower at pH 5.5 and was not detected when
the pH was higher than this (Fig. 10 a). This correlated
with the enzymatic activity which exhibited a pH optimum
of 5 (Fig. 10 a). When the Golgi fraction was incubated in
the absence of calcium and in the presence of EDTA, pro
PC2 maturation was partly inhibited, and PC2 activity was
completely inhibited (Fig. 10 b). These results are consis-
tent with the data available concerning PC2 activity (Ben-
nett et al., 1992; Lindberg et al., 1995; Shennan et al., 1995;
Lamango et al., 1996).
7B2 Protects ProPC2 from Inactivation at Low pH
In the experiments described above, the conversion of
proPC2 was not complete: only 20% of the proPC2
present in the Golgi fraction was converted into mature
PC2 (Fig. 9 a). This proportion could not be increased by
extending the incubation period (not shown). We studied,
therefore, the role of 7B2 and low pH independently by
preincubating the Golgi fraction under different condi-
tions and in the presence of detergent. When the mem-
branes were preincubated at pH 5 in the absence of 7B2,
no mature PC2 was formed (Fig. 11 a). Subsequent addi-
Figure 10. 7B2-induced activation of proPC2 is pH and calcium dependent. (a) Golgi-enriched membranes were incubated at different
pH at 378C in the presence of 200 nM recombinant 21-kD 7B2. The reaction was stopped by the addition of Laemmli sample buffer and
boiled for 5 min before PC2 immunoblotting. (b) Golgi-enriched membranes were incubated in the presence or absence of 200 nM re-
combinant 21-kD 7B2 (21 kD) and of 5 mM calcium at 378C for 30 min. When calcium was omitted, it was replaced by 2 mM EDTA.
The reaction was stopped by the addition of Laemmli sample buffer and boiled for 5 min before PC2 immunoblotting. Alternatively, the
same incubations were performed to measure PC2 activity. Activity measurements are presented on the bottom line under the immuno-
blots as percent of the maximum activity detected.
Table II. Characterization of Subcellular Fractions
S1 Golgi ER
Galactosyl transferase (cpm/mg) 72 260 44
BiP (A.U.) 130 51 136
proPC2 1 PC2 (mg/mg protein) 19 35 29
proPC2 1 PC2 (mg) 93 14 30
Subcellular fractions were assayed for galactosyl transferase activity as described in
Materials and Methods. Proteins of the fractions were separated by SDS-PAGE and
transferred to nitrocellulose. BiP and PC2 immunoreactivity was detected using the
Vistra Western blot substrate and quantitated with a phosphorimager. BiP immunore-
activity is expressed in arbitrary units (A.U.). The total PC2 content was calculated
using PC2 purified from CHO cell medium as a reference.
Figure 9. 7B2-induced activation of proPC2 from Golgi mem-
branes. (a) Subcellular fractions (3 mg protein) corresponding to
the supernatant of the first centrifugation (S1) and to Golgi- and
ER-enriched membranes were incubated at pH 5 at 378C for 30
min in the presence or absence of 200 nM recombinant 21-kD
7B2 (21 kD) and of 1 mM CT peptide (CT). The reaction was
stopped by the addition of Laemmli sample buffer and boiled for
5 min before PC2 immunoblotting. (b) Subcellular fractions (1 mg
protein) were incubated under the same conditions as in a and in
the presence of 200 mM Pyr-Glu-Arg-Thr-Lys-Arg-AMC. Fluo-
rescence was measured and PC2 specific activity was calculated.
Black bars correspond to the control incubations, grey bars to the
incubations with the recombinant 21-kD 7B2, and white bars to the
incubation with the recombinant 21-kD 7B2 and the CT peptide.The Journal of Cell Biology, Volume 139, 1997 634
tion of 7B2 to these membranes did not result in the pro-
duction of mature PC2 (Fig. 11 b), nor of PC2 activity (Fig.
11  c). We hypothesize that exposure of proPC2 to an
acidic pH results in its irreversible inactivation, and that
7B2 has a protective role on proPC2 activatable conforma-
tion. We have previously observed that 7B2 can protect
PC2 from thermal denaturation (Lamango et al., 1996).
When membranes were preincubated in the presence of
the 21-kD 7B2 at pH 7.4, no mature PC2 was formed (Fig.
11 a). Lowering the pH of the incubation medium to 5,
however resulted in the conversion of proPC2 into PC2
(Fig. 11 b), and in the detection of PC2 activity (Fig. 11 c).
Such preincubation of the membranes for longer periods
up to 2 h could not significantly increase the PC2 activity
detected during the subsequent incubation, however (data
not shown). This suggests that 7B2 does not per se confer
an activatable conformation to proPC2, but rather inter-
acts with a conformation that proPC2 has already achieved
and that is competent for activation.
Discussion
The neuroendocrine protein 7B2 is a PC2-specific binding
protein that facilitates proPC2 maturation in vivo (Zhu
and Lindberg, 1995) as well as in vitro (Braks and Mar-
tens, 1995) and is required for the expression of PC2 activ-
ity in the medium of CHO cells (Zhu and Lindberg, 1995).
The mechanism of these interactions has, however, not yet
been determined. 7B2 could be involved in several steps of
proPC2 posttranslational processing: folding in the ER,
transport to the Golgi, or conversion into mature PC2.
Binding of 7B2 to ProPC2 Is a Late ER Event
7B2 and proPC2 bind within the secretory pathway (Braks
and Martens, 1994). Both proteins are subject to proteo-
lytic processing after their sulfation in the TGN (Benjan-
net et al., 1993; Paquet et al., 1994). There is, however,
some discrepancy as to how these cleavages affect the co-
immunoprecipitation of the two proteins (Fig. 1; Benjan-
net et al., 1995; Braks et al., 1996). These studies all agree
on the binding of the 27-kD form of 7B2 to proPC2. Ex-
periments using brefeldin A have demonstrated that this
binding occurred before the molecules reach the TGN (Ben-
jannet et al., 1995; Braks et al., 1996). As this fungal me-
tabolite blocks intracellular transport out of the ER and
fuses the Golgi saccules with the ER cisternae, it does not
constitute an appropriate tool to distinguish ER from Golgi
events (for review see Klausner et al., 1992). The coimmu-
noprecipitation of 7B2 with endoglycosidase H–sensitive
proPC2 that we describe here more directly demonstrates
that the complex is actually formed in the ER. Sulfation
experiments suggest that 7B2 and proPC2 are transported
to the TGN as a complex (Benjannet et al., 1995), which is
in agreement with our analysis of the endoglycosidase H
resistance of the 7B2-bound proPC2. However, the kinet-
ics of cleavage and secretion of 7B2 and PC2 are very dif-
ferent from each other (Guest et al., 1992; Benjannet et al.,
1993; Shen et al., 1993; Paquet et al., 1994; Zhou and Mains,
1994; Zhu and Lindberg, 1995). These kinetics are at ap-
parent variance with the hypothesis of the binding of 7B2
to proPC2 in the ER followed by transport of the complex
to the Golgi. The comparison between the release of newly
synthesized and sulfated 7B2 and PC2 demonstrate that
7B2 and PC2 are not transported from the ER to the Golgi
at the same rate after their syntheses. These two proteins,
therefore, do not spend the same amount of time in the
ER before they can bind to each other. Indeed, our kinetic
experiments demonstrate that whereas newly synthesized
7B2 could bind to proPC2 soon after synthesis, newly syn-
thesized proPC2 could not bind to 7B2 before a further
chase. The 7B2–proPC2 complex is formed, therefore, in
the ER with 7B2 and proPC2 molecules that have not been
synthesized at the same time: proPC2 is older than the 7B2
to which it is bound. Finally, analysis of 7B2-bound pro-
PC2 acquisition of endoglycosidase H resistance demon-
strated that the complex is not accumulated in the ER but
is rapidly transported to the Golgi. Therefore, the associa-
tion of 7B2 with proPC2 represents a late event in the time
period that proPC2 spends in the ER.
7B2 Is Not Involved in ProPC2 Folding
Previous studies of PC2 and 7B2 biosynthesis provided ev-
idence for another important difference between 7B2 and
proPC2 exit from the ER: whereas radiolabeled 7B2 exits
the ER as a homogenous pool within a short time span, the
exit of a radiolabeled population of proPC2 molecules is
widely spread in time (Guest et al., 1992; Benjannet et al.,
1993; Shen et al., 1993; Paquet et al., 1994; Zhou and
Mains, 1994; Zhu and Lindberg, 1995). In this paper we
have also shown that whereas proPC2 secretion is sensi-
tive to DTT treatment, 7B2 secretion is not, even though
both proteins contain disulfide bridges. These results sug-
gest differing requirements for 7B2 and proPC2 folding in
the ER. The time spent in the ER is directly related to the
folding of the proteins (for review see Lodish, 1988), and
Figure 11. 7B2 can protect
proPC2 from inactivation at
low pH. (a) Golgi-enriched
membranes were preincu-
bated (pre) in the presence
or absence of 200 nM recom-
binant 21 kD 7B2 (21 kD)
and of 100 mM Na acetate,
pH 5, at 378C. After a 30-min
preincubation, the reactions
were stopped by the addition
of Laemmli sample buffer
and boiled for 5 min before
PC2 immunoblotting. (b)
Membranes which had been
preincubated as described in
a were then incubated in com-
plete medium containing re-
combinant 7B2 and 100 mM
Na acetate, pH 5, buffer at
378C. After a 30-min incuba-
tion, the reactions were
stopped by the addition of Laemmli sample buffer and boiled for
5 min before PC2 immunoblotting. (c) Alternatively, the same
preincubations and incubations were performed to measure PC2
activity. Activity measurements correspond to the incubation pe-
riods. Results are expressed as percent of the maximum activity
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the long period that proPC2 requires in the ER environment
could reflect the complex folding of this particular protein.
Like other members of the subtilisin-like convertase fam-
ily, PC2 is synthesized as a proenzyme. Though the pri-
mary structure of the propeptide is poorly conserved be-
tween the PCs, its general organization is similar. In the
case of subtilisin, the propeptide acts as an intramolecular
chaperone (Zhu et al., 1989). This chaperone activity of
the propeptide has been extended to the other subtilisin-
like enzymes based on structural homologies (Siezen et al.,
1995). Because PC2 is retained in the ER longer than the
other PCs, it could be hypothesized that it may require
some specific intermolecular chaperone activities. 7B2 could
fulfill such a function, even though it is a secretory protein.
Whereas the molecular chaperones present within the sec-
retory pathway were at first restricted to ER-resident pro-
teins, this notion has been extended, as members of the
heat shock protein family cycle between the Golgi and the
ER (Hammond and Helenius, 1994; Satoh et al., 1996) and
as other secretory proteins, such as the receptor-associated
protein (RAP), have been shown to exhibit chaperone ac-
tivity in the ER (Bu and Rennke, 1996; Willnow et al.,
1996). However, our experiments indicate that 7B2 does
not modify the aggregation state of proPC2 in the ER nor
the sensitivity of native proPC2 to N-glycanase F diges-
tion. 7B2 does not modify the pattern of association of
proPC2 with traditional chaperones like BiP/GRP78 or
calnexin. We could also demonstrate that prevention of
proper proPC2 folding suppresses rather than enhances
7B2 binding. Two additional lines of evidence are in agree-
ment with the lack of involvement of 7B2 in proPC2 fold-
ing. First, preincubating subcellular membranes with re-
combinant 7B2 for increasing periods did not result in an
increase of proPC2 activation, suggesting that 7B2 alone
could not provide a proper conformation, but could only
act on already properly folded proPC2. Second, swapping
the PC2 proregion with furin and PC1 propeptide demon-
strated that the PC2 propeptide is required for the binding
of proPC2 to 7B2, but is not sufficient to confer 7B2 bind-
ing to PC1 (Zhu, X., unpublished results), thus suggesting
that the propeptide is required for the proper folding of
proPC2 (Siezen et al., 1995) rather than directly for 7B2
binding. Taken together, these various lines of evidence
lead to the conclusion that 7B2 is not involved in the early
steps of proPC2 folding and cannot be considered a bona
fide folding chaperone.
7B2 Increases ProPC2 Transport to the Golgi
As 7B2 binds proPC2 in the ER, we investigated the effect
of this binding on the exit from the ER and transport to
the Golgi under experimental conditions that prevent pro-
PC2 cleavage. Coexpression of 7B2 resulted in increased
proPC2 acquisition of endoglycosidase H resistance, which
paralleled the facilitation of proPC2 maturation (Zhu and
Lindberg, 1995). This effect on proPC2 transport to the
Golgi occurred through the binding of proPC2 to 7B2. 7B2
could act by stabilizing proPC2 in a conformation that is
more transport competent. Indeed, we could demonstrate
that 7B2-bound proPC2 does not accumulate in the ER but
exits rapidly after the formation of the complex. Though
potential differences in affinity between the antiserum di-
rected against PC2 and that directed against 7B2 do not
permit us to quantitate the proportion of proPC2 that
reaches the Golgi bound to 7B2, our immunoprecipitation
data indicate that the same amounts of total proPC2 and
7B2-bound proPC2 acquire endoglycosidase H resistance.
These data imply that in AtT-20 cells, proPC2 reaches the
Golgi mainly as a complex with 7B2, which could explain
the high efficiency of 7B2 in promoting proPC2 matura-
tion in AtT-20 cells. Studies using several constitutive cell
lines that lack 7B2 have demonstrated, however, that
proPC2 can, in fact, exit the ER in the absence of 7B2
(Benjannet et al., 1993; Shen et al., 1993). Rather than ac-
tually providing a transport-competent conformation to
proPC2, which would be indicative of a folding activity, or
providing transport competence to proPC2, which is ap-
parently not required in constitutive cell lines, we propose
that 7B2 stabilizes a transport-competent conformation of
proPC2. This stabilization results in an increase in trans-
port to the Golgi, which would nevertheless occur, albeit
at a slower rate, without 7B2.
7B2 Is Required for ProPC2 Activation
Apart from the facilitation of proPC2 maturation, which
could be explained by the increased transport of proPC2
only, 7B2 is also required to obtain activatable proPC2 from
Figure 12. Schematic representation of
the steps of proPC2 posttranslational mat-
uration in which 7B2 is involved. (1) 7B2
binds to folded proPC2 but not to un-
folded proPC2. (2) The proPC2–7B2 com-
plex formed in the ER is transported to
the Golgi at a higher rate than proPC2 is
alone (double arrow). (3) 7B2-bound
proPC2 can undergo activation when it
reaches the TGN/secretory granules
which possess the requisite low pH and
high calcium environment. PC2 propep-
tide is represented by the VVVV. Only
two of the three potential glycosylation
sites of PC2 are represented by the Y. The
acquisition of endoglycosidase H resis-
tance by one of the two oligosaccharides is
indicated by s.The Journal of Cell Biology, Volume 139, 1997 636
the medium of CHO cells (Zhu and Lindberg, 1995; La-
mango et al., 1996). To study the conditions required for
7B2 effects on proPC2 activatability, we used an in vitro
system based on the subcellular fractionation of CHO cells
that express PC2 but not 7B2. Adding recombinant 21-kD
7B2 to the membrane fractions at pH 5 in the presence of
detergent and calcium resulted in the detection of proPC2
conversion and PC2 activity. This demonstrates the direct
involvement of 7B2 in the activation process of proPC2.
The greatest quantity of activatable proPC2 was present in
the Golgi fraction, which is consistent with our observa-
tion that 7B2 binds to folded proPC2. Our in vitro system
permitted us to correlate proPC2 activity with the removal
of the propeptide. We could observe, however, the forma-
tion of some 66-kD mature PC2 without detecting PC2 ac-
tivity when membranes were incubated in the absence of
detergent, thus preventing the presence of 7B2 in the mem-
brane compartments that contain proPC2 (not shown).
These experimental conditions resemble a physiological
situation in which proPC2 reaches an acidic pH in the
TGN with removal of the propeptide in the absence of
7B2. Indeed, proPC2 is released as a mixture of proPC2
and processed PC2 from constitutive cells lacking 7B2 (Ben-
jannet et al., 1993; Shen et al., 1993). This released pro-
PC2/PC2 is neither active nor activatable, however (Shen
et al., 1993). In fact, 7B2 coexpression did not modify the
kinetics of proPC2 secretion from CHO cells, but in-
creased the ratio of proPC2/PC2 present in the secretion
medium (Liu, J., I. Lindberg, and L. Muller, unpublished
observations). The same increased ratio of proPC2/PC2 in
the presence of 7B2 has been described in BSC40 cells
(Benjannet et al., 1995). We have also recently identified a
point mutation in the PC2 catalytic domain that uncouples
removal of the propeptide from actual activation, i.e., ac-
quisition of enzymatic activity: this mutation results in an
increased rate of propeptide removal, but also a lack of
7B2 binding and of enzyme activity (Zhu, X., unpublished
observations). Taken together, these data demonstrate
that whereas the PC2 propeptide can be cleaved from
proPC2 in the absence of 7B2, this cleavage only results in
the formation of inactive enzyme. These data support a di-
rect link between 7B2 and proPC2 activation.
Our experimental system of in vitro activation of the pro-
PC2 present in the Golgi membranes of CHO cells, how-
ever, does not permit us to determine the mechanistic dif-
ference between the conversion of proPC2 to an active
or inactive form. The cleavage site of proPC2 propeptide
(RKKR) is a consensus site for several PCs, including fu-
rin, which is responsible for the cleavage of proproteins in
the constitutive pathway. The autocatalytic conversion of
proPC2 has been proposed (Matthews et al., 1994), and is
by analogy with furin, PC1 and subtilisin most probably in-
tramolecular, but it is not known whether the unproduc-
tive cleavage of proPC2, i.e., the cleavage of the propep-
tide that results in the production of an inactive enzyme, is
also autocatalytic, or if another enzyme is involved.
Taken together, our results provide a general scheme of
the interaction of 7B2 with proPC2 within the neuroen-
docrine secretory pathway (Fig. 12). ProPC2 folding is a
slow process. Whereas PC2 propeptide might be involved
in this folding, 7B2 does not seem to be actively involved
in the early steps. This process could consist in the cycling
of proPC2 between partially folded intermediates and
an unstable folded transport-competent form which could
be stabilized by 7B2. This stabilization results in the in-
crease of proPC2 transport to the Golgi. Once the com-
plex has reached the Golgi, proPC2 oligosaccharides un-
dergo their maturation before processing of proPC2 in the
TGN/secretory granules. The low pH and high calcium of
these intracellular compartments triggers the conversion
of proPC2 into mature PC2. The proPC2 bound to 7B2
will undergo an activation process, whereas the free proPC2
will also be processed, most probably in the same subcellu-
lar compartments, but will not thereby be activated. Our
experiments demonstrate, therefore, that 7B2, which is
neither a folding chaperone nor a subunit of the enzymatic
complex, can actually induce the activation of proPC2 ac-
cording to a unique pathway. Our experimental system of
proPC2 maturation in vitro from subcellular fractions
should permit us to study more precisely the molecular
mechanism of PC2 activation in the presence of 7B2.
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